Endo, Arnold & Porter Split Amid Opioid Litigation Troubles

By Jeff Overley · October 29, 2021, 7:33 PM EDT

Amid a major controversy over discovery shortcomings, Endo Pharmaceuticals disclosed late Friday that Arnold & Porter is departing as its counsel in multidistrict opioid litigation and being replaced by Skadden....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

1:17-md-02804

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022